Hostname: page-component-cd9895bd7-7cvxr Total loading time: 0 Render date: 2024-12-25T19:41:17.161Z Has data issue: false hasContentIssue false

Olanzapine versus risperidone: weight gain and elevation of serum triglyceride levels

Published online by Cambridge University Press:  16 April 2020

George Garyfallos*
Affiliation:
The B’ University Department of Psychiatry, Aristotelian University of Thessaloniki, Thessaloniki, Greece
Dimos Dimelis
Affiliation:
The B’ University Department of Psychiatry, Aristotelian University of Thessaloniki, Thessaloniki, Greece
Philippos Kouniakis
Affiliation:
The B’ University Department of Psychiatry, Aristotelian University of Thessaloniki, Thessaloniki, Greece
Nikos Sidiropoulos
Affiliation:
The B’ University Department of Psychiatry, Aristotelian University of Thessaloniki, Thessaloniki, Greece
Anastasia Karastergiou
Affiliation:
The B’ University Department of Psychiatry, Aristotelian University of Thessaloniki, Thessaloniki, Greece
Grigoris Lavrentiadis
Affiliation:
The B’ University Department of Psychiatry, Aristotelian University of Thessaloniki, Thessaloniki, Greece
John Giouzepas
Affiliation:
The B’ University Department of Psychiatry, Aristotelian University of Thessaloniki, Thessaloniki, Greece
Kostas Fokas
Affiliation:
The B’ University Department of Psychiatry, Aristotelian University of Thessaloniki, Thessaloniki, Greece
*
*Corresponding author. Present address: Community Mental Health Center, 20 Papadopoulou Str-Sikies, 56625 Thessaloniki, Greece. E-mail address:anakar@med.auth.gr (G. Garyfallos).
Get access

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Case report
Copyright
Copyright © Éditions scientifiques et médicales Elsevier SAS 2003

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Allison, D, Mentore, J, Heo, M, et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999;156;1686-96.Google ScholarPubMed
Osser, D, Najarian, D, Dufresne, R. Olanzapine increases weight and serum triglyceride levels. J Clin Psychiatry 1999;60;767-70.CrossRefGoogle ScholarPubMed
Melkerson, K, Hulting, AL, Brismar, K. Elevated levels of insulin, leptin and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses. J Clin Psychiatry 2000;61;742-9.CrossRefGoogle Scholar
Lamberti, J, Bellnier, T, Schwarzkopf, S. Weight gain among schizophrenic patients treated with clozapine. Am J Psychiatry 1992;149;689-90.Google ScholarPubMed
Basson, B, Kinon, B, Taylor, C, Szymanski, K, Gilmore, J, Tollefson, G. Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol or risperidone. J Clin Psychiatry 2001;62;231-8.CrossRefGoogle ScholarPubMed
Donias, S, Manavis, H, Delapaschou, E, Garyfallos, G, Paraschos, A. The Positive and Negative Syndrome Scale for schizophrenia: reliability and validity of the Greek standardized version. Psychiatriki 1996;7;60-5 [in Greek].Google Scholar
Conley, R, Mahmoud, R. A randomized doule-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder. Am J Psychiatry 2001;158;765-74.CrossRefGoogle ScholarPubMed
Wirshing, D, Wirshing, W, Kysar, L, et al. Novel antipsychotics: comparison of weight gain liabilities. J Clin Psychiatry 1999;60;358-63.CrossRefGoogle ScholarPubMed
Gaulin, B, Markowitz, J, Caley, C, Nesbitt, L, Dufresne, R. Clozapine-associated elevation in serum triglycerides. Am J Psychiatry 1999;156;1270-2.Google ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.